Rezolute (RZLT) Change in Inventory (2014 - 2015)
Rezolute recorded quarterly Change in Inventory of $119540.0 in Q3 2015, up 574.23% quarter-over-quarter from -$25207.0 in Q2 2015, and up 871.71% year-over-year from $12302.0 in Q3 2014.
Rezolute's Change in Inventory history runs 2 years deep, the most recent figure standing at $119540.0 for Q3 2015.
- In Q3 2015, Change in Inventory rose 871.71% year-over-year to $119540.0; the TTM figure through Sep 2015 stood at -$115144.0 (down 245.93% YoY), while the FY2015 annual figure was -$222382.0, down 433.91% from the prior year.
- Change in Inventory came in at $119540.0 for Q3 2015 at Rezolute, up from -$25207.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $119540.0 in Q3 2015 to a low of -$225767.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 119,540.00 |
| Sep 30, 2015 | 119,540.00 |
| Jun 30, 2015 | -25,207.00 |
| Jun 30, 2015 | -25,207.00 |
| Mar 31, 2015 | 16,290.00 |
| Mar 31, 2015 | 16,290.00 |
| Dec 31, 2014 | -225,767.00 |
| Dec 31, 2014 | -225,767.00 |
| Sep 30, 2014 | 12,302.00 |
| Sep 30, 2014 | 12,302.00 |
| Jun 30, 2014 | 66,600.00 |
| Jun 30, 2014 | 66,600.00 |